Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.hikal.com | |
Market Cap | 4,438.21 Cr. | |
Enterprise Value(EV) | 5,139.37 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 6.64 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 53.90 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 87.56 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 4.09 | Calculated using Price: 358.00 |
Dividend Yield | 0.44 | Period Ending 2022-03 |
No. of Shares Subscribed | 12.33 Cr. | 123,300,750 Shares |
FaceValue | 2 | |
Company Profile | ||
Established in 1988 Hikal is a reliable partner to companies in the Pharmaceuticals, Biotech, Agrochemicals and Specialty Chemicals industries. They provide world-class Active Ingredients, Intermediates and R&D services and solutions in a safe, secure and confidential manner. Their advanced infrastructure has been inspected and approved by globally recognized bodies such as the USFDA. |
1 Day |
|
-2.61% |
1 Week |
|
-7.54% |
1 Month |
|
-0.32% |
3 Month |
|
+8.78% |
6 Month |
|
+44.76% |
1 Year |
|
-5.22% |
2 Year |
|
+109.42% |
5 Year |
|
+136.66% |
10 Year |
|
+520.24% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 17.27 | 9.81 | 9.32 | 12.74 | 12.12 | 14.46 | 10.74 | 15.22 | 16.04 | |
Return on Capital Employed (%) | 17.77 | 12.50 | 11.92 | 11.87 | 12.81 | 15.25 | 12.44 | 16.15 | 15.21 | |
Return on Assets (%) | 5.17 | 3.12 | 3.17 | 5.02 | 5.15 | 6.11 | 4.62 | 6.84 | 7.39 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 505 | 532 | 564 | 605 | 669 | 756 | 817 | 933 | 1,068 | 1,080 | |
Non Curr. Liab. | 298 | 242 | 337 | 324 | 312 | 359 | 410 | 379 | 432 | 427 | |
Curr. Liab. | 479 | 530 | 397 | 470 | 616 | 659 | 653 | 703 | 828 | 812 | |
Minority Int. | |||||||||||
Equity & Liab. | 1,282 | 1,304 | 1,298 | 1,400 | 1,597 | 1,775 | 1,879 | 2,016 | 2,328 | 2,319 | |
Non Curr. Assets | 775 | 791 | 808 | 793 | 851 | 888 | 1,048 | 1,091 | 1,305 | 1,333 | |
Curr. Assets | 507 | 513 | 490 | 607 | 746 | 886 | 831 | 925 | 1,023 | 986 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 1,282 | 1,304 | 1,298 | 1,400 | 1,597 | 1,775 | 1,879 | 2,016 | 2,328 | 2,319 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 829 | 872 | 926 | 1,014 | 1,296 | 1,590 | 1,507 | 1,720 | 1,943 | 1,954 | |
Other Income | 34 | 2 | 2 | 3 | 4 | 2 | 4 | 5 | 5 | 5 | |
Total Income | 863 | 873 | 927 | 1,017 | 1,301 | 1,592 | 1,511 | 1,725 | 1,948 | 1,960 | |
Total Expenditure | -642 | -689 | -745 | -815 | -1,054 | -1,291 | -1,234 | -1,398 | -1,602 | -1,708 | |
PBIDT | 221 | 184 | 183 | 202 | 246 | 300 | 277 | 328 | 345 | 252 | |
Interest | -68 | -60 | -62 | -48 | -49 | -58 | -52 | -36 | -31 | -37 | |
Depreciation | -55 | -64 | -67 | -69 | -86 | -93 | -82 | -85 | -96 | -103 | |
Taxation | -34 | -19 | -12 | -13 | -34 | -46 | -42 | -73 | -58 | -30 | |
Exceptional Items | -4 | -15 | |||||||||
PAT | 64 | 40 | 41 | 68 | 77 | 103 | 84 | 133 | 161 | 82 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 64 | 40 | 41 | 68 | 77 | 103 | 84 | 133 | 161 | 82 | |
Adjusted EPS | 5 | 3 | 3 | 5 | 6 | 8 | 7 | 11 | 13 | 7 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 61 | 154 | 102 | 186 | 163 | 139 | 186 | 285 | 229 | 294 | |
Cash Fr. Inv. | -28 | -23 | -43 | -64 | -102 | -110 | -125 | -164 | -156 | -284 | |
Cash Fr. Finan. | -27 | -124 | -69 | -124 | -63 | -25 | -55 | -101 | -97 | -6 | |
Net Change | 6 | 7 | -10 | -2 | -2 | 4 | 6 | 20 | -24 | 4 | |
Cash & Cash Eqvt | 9 | 16 | 6 | 4 | 2 | 6 | 11 | 32 | 8 | 11 |
Wed, 25 Jan 2023
Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results For The Quarter And Period Ended December 31 2022 And Interim Dividend HIKAL LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve a. Standalone and Consolidated Unaudited Financial Results of the Company for the quarter and period ended December 31 2022; and b. to consider payment of interim dividend if any on the equity shares of the Company for the financial year 2022-23. |
Wed, 25 Jan 2023
Corporate Action-Board to consider Dividend Board is to consider payment of interim dividend if any on the equity shares of the Company for the financial year 2022-23. |
Tue, 17 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Certificate under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations 2018 for the quarter ended December 31 2022 |
Fri, 27 Jan 2023 |
|
|
|
|
|